≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Mental and behavioural disorders due to hallucinogens

DOID EFO Endpoint Browser PheWeb

F5_HALLUCIN

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F16
  • Hospital discharge: ICD-9 — 3045|3053
  • Hospital discharge: ICD-8 — 3047
  • Cause of death: ICD-10 — F16
  • Cause of death: ICD-9 — 3045|3053
  • Cause of death: ICD-8 — 3047

2 out of 7 registries used, show all original rules.

196

4. Check minimum number of events

None

196

5. Include endpoints

None

196

6. Filter based on genotype QC (FinnGen only)

196

Control definitions (FinnGen only)

Control exclude
F5_SUBSNOALCO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F10-F19
Name in latin
Perturbationes mentis et modi se gerendi ex usu hallucinogenum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2511 605 1885
Only index persons 2244 557 1687
Unadjusted period prevalence (%)
Whole population 0.04 0.02 0.05
Only index persons 0.05 0.02 0.06
Median age at first event (years)
Whole population 24.55 23.22 24.95
Only index persons 24.23 23.08 24.61

-FinnGen-

Key figures

All Female Male
Number of individuals 196 67 129
Unadjusted period prevalence (%) 0.05 0.02 0.06
Median age at first event (years) 25.09 25.10 25.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
188
Matched controls
1880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B18.2
ICD-10 Finland
Chronic viral hepatitis C
344.0
96.4
90
5
N05AH03
ATC
olanzapine; systemic
39.5
82.9
109
63
F29
ICD-10 Finland
Unspecified nonorganic psychosis
38.4
77.7
102
56
T36
ICD-10 Finland
Poisoning by systemic antibiotics
63.3
72.5
83
23
N05AH04
ATC
quetiapine; oral
18.9
68.4
130
199
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
24.5
67.5
104
90
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
909.9
67.3
62
*
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
+∞
66.7
60
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
+∞
60.8
55
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
56.9
57.5
67
18
P19
ICPC
Drug abuse
118.6
55.7
58
7
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
24.6
55.4
82
57
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
+∞
54.9
50
*
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
+∞
53.8
49
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
19.8
50.4
81
69
N05AX08
ATC
risperidone; systemic
20.5
50.0
79
64
F16.1
ICD-10 Finland
Mental and behavioural disorders due to use of hallucinogens, harmful use
+∞
43.4
40
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
+∞
42.3
39
*
Z72.2
ICD-10 Finland
Drug use
498.6
41.8
40
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
+∞
40.0
37
*
N05AA02
ATC
levomepromazine; systemic
32.2
39.3
52
22
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
+∞
37.8
35
*
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
+∞
37.8
35
*
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
+∞
36.7
34
*
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
+∞
36.7
34
*
N05BA01
ATC
diazepam; systemic, rectal
12.3
36.5
72
90
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
42.3
35.0
43
13
N05AX12
ATC
aripiprazole; systemic
14.8
33.6
59
56
N07BB01
ATC
disulfiram; oral
16.7
32.1
53
43
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
30.4
30.8
41
17
N05CD07
ATC
temazepam; oral
18.0
30.8
49
36
N05AF03
ATC
chlorprothixene; systemic
39.2
30.5
38
12
N05BA04
ATC
oxazepam; oral
6.8
29.1
90
222
N03AG01
ATC
valproic acid; systemic, rectal
13.2
28.9
53
54
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
28.9
27
*
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
327.4
28.6
28
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
7.4
28.3
79
168
N05AH02
ATC
clozapine; systemic
22.7
27.6
40
22
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
113.6
27.5
29
*
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
+∞
26.7
25
*
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
+∞
26.7
25
*
Z2446
NOMESCO Finland
Social worker
11.9
26.5
51
57
N03AE01
ATC
clonazepam; systemic
17.7
26.4
42
30
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
30.3
26.4
35
14
P18
ICPC
Medication abuse
299.6
26.4
26
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
31.6
25.9
34
13
F16.09
ICD-10 Finland
Intoxication caused by hallucinogens UNS
+∞
25.6
24
*
N06AX11
ATC
mirtazapine; oral
5.6
25.2
97
302
F10.25
ICD-10 Finland
Alcohol dependence continuous use
56.7
25.1
29
6
F10.20
ICD-10 Finland
Alcohol dependence currently independent
25.6
24.5
34
16
N05BA12
ATC
alprazolam; oral
10.4
24.3
50
63
N05AD01
ATC
haloperidol; systemic
29.3
24.0
32
13
N05CF01
ATC
zopiclone; oral
5.9
23.4
78
201
N06AB04
ATC
citalopram; systemic
6.0
23.0
74
182
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
+∞
22.3
21
*
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
91.3
22.2
24
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
130.2
22.1
23
*
C07AA05
ATC
propranolol; systemic
5.5
22.0
78
213
A46
ICD-10 Finland
Erysipelas
9.0
21.8
49
71
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
16.3
21.6
35
26
F20.9
ICD-10 Finland
Schizophrenia, unspecified
21.5
21.3
31
17
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
12.3
21.1
39
39
ZY000
NOMESCO Finland
Hospital inpatient
47.7
21.0
25
6
N06AX16
ATC
venlafaxine; oral
6.3
21.0
63
139
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
234.8
21.0
21
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
24.2
20.7
29
14
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
28.4
20.2
27
11
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
+∞
20.2
19
*
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
222.3
20.0
20
*
P15
ICPC
Chronic alcohol abuse
14.0
19.2
33
28
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
13.1
19.2
34
31
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
+∞
19.1
18
*
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
+∞
19.1
18
*
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
+∞
19.1
18
*
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
+∞
19.1
18
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.9
19.0
59
134
N06AB06
ATC
sertraline; oral
6.3
18.8
55
116
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
30.3
18.3
24
9
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
5.9
18.1
56
126
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
+∞
18.0
17
*
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
+∞
18.0
17
*
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
+∞
18.0
17
*
ZY010
NOMESCO Finland
Hospital outpatient
9.0
17.9
39
53
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
197.8
17.8
18
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
8.3
17.8
41
61
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
12.2
17.5
32
31
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
24.8
17.4
24
11
Z3231
NOMESCO Finland
Registered nurse
4.5
17.3
74
236
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
11.8
17.2
32
32
EBA00
NOMESCO Finland
Extraction of tooth
3.9
17.2
102
436
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
+∞
16.9
16
*
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
+∞
16.9
16
*
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
+∞
16.9
16
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
22.7
16.9
24
12
F20.0
ICD-10 Finland
Paranoid schizophrenia
185.7
16.8
17
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.3
16.5
35
45
N05AB03
ATC
perphenazine; systemic, rectal
14.1
16.5
28
23
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
10.8
16.5
32
35
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
13.0
16.4
29
26
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
12.1
16.4
30
29
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
52.5
16.3
19
*
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
24.7
16.0
22
10
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
9.5
15.9
33
41
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
+∞
15.8
15
*
F12.29
ICD-10 Finland
Addiction caused by cannabis UNS
+∞
15.8
15
*
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
93.0
15.8
17
*
F05.9
ICD-10 Finland
Delirium, unspecified
173.8
15.7
16
*
F10.24
ICD-10 Finland
Alcohol depence active use
41.9
15.7
19
5
T74.1
ICD-10 Finland
Physical abuse
19.9
15.6
23
13
T51.0
ICD-10 Finland
Toxic effect: Ethanol
61.9
15.0
17
*
N06AB03
ATC
fluoxetine; oral
5.2
14.9
50
122
IGY02
NOMESCO Finland
Psychiatric monitoring contact
11.9
14.8
27
26
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.7
14.7
35
54
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
19.0
14.7
22
13
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
8.7
14.7
32
43
N04AA02
ATC
biperiden; systemic
29.9
14.6
19
7
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
10.7
14.0
27
29
N06AB10
ATC
escitalopram; oral
3.8
13.9
72
264
P01
ICPC
Feeling anxious/nervous/tense
4.4
13.9
57
170
F61.0
ICD-10 Finland
Mixed personality disorders
18.0
13.8
21
13
AA1AD
NOMESCO Finland
CT of head and brain
4.5
13.8
54
154
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
28.2
13.6
18
7
B17.1
ICD-10 Finland
Acute hepatitis C
150.3
13.6
14
*
N06AB05
ATC
paroxetine; oral
6.9
13.4
34
58
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
30.9
13.2
17
6
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
24.7
13.2
18
8
N05AA01
ATC
chlorpromazine; systemic, rectal
24.7
13.2
18
8
N05AF05
ATC
zuclopenthixol; systemic
24.7
13.2
18
8
SPAT1272
SPAT
Drug screening
53.9
13.0
15
*
F20
ICD-10 Finland
Schizophrenia
53.9
13.0
15
*
S01.0
ICD-10 Finland
Open wound of scalp
7.4
12.8
31
49
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
34.7
12.8
16
5
N06AA12
ATC
doxepin; systemic
14.6
12.8
21
16
N05BA02
ATC
chlordiazepoxide; systemic
21.9
12.7
18
9
N05BA06
ATC
lorazepam; systemic, sublingual
12.9
12.7
22
19
3049X
ICD-9 Finland
Drug dependence, Unspecified drug dependence
+∞
12.6
12
*
F19.50
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic
+∞
12.6
12
*
S06.0
ICD-10 Finland
Concussion
5.1
12.5
42
101
X78
ICD-10 Finland
Intentional self-harm by sharp object
40.4
12.4
15
*
P72
ICPC
Schizophrenia
14.7
12.3
20
15
P98
ICPC
Psychosis NOS/other
23.2
12.2
17
8
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
13.0
12.2
21
18
EBA05
NOMESCO Finland
Complicated extraction of tooth
3.7
12.0
60
210
R41.0
ICD-10 Finland
Disorientation, unspecified
50.0
12.0
14
*
Z71.8
ICD-10 Finland
Other specified counselling
3.4
12.0
72
289
N05BE01
ATC
buspirone; oral
13.8
11.9
20
16
N05AN01
ATC
lithium; oral
12.3
11.9
21
19
Z2445
NOMESCO Finland
Psychologist
7.5
11.8
28
43
XF400
NOMESCO Finland
ECG with 12 standard connections
5.1
11.8
39
92
P16
ICPC
Acute alcohol abuse
14.9
11.7
19
14
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
+∞
11.6
11
*
F16.59
ICD-10 Finland
Psychotic disorder caused by UNS 'hallucinogens
+∞
11.6
11
*
N05AB01
ATC
dixyrazine; systemic
+∞
11.6
11
*
F12.5
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, psychotic disorder
+∞
11.6
11
*
SPAT1265
SPAT
Breathalyser
16.4
11.6
18
12
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
127.4
11.6
12
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.2
11.5
48
143
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
9.5
11.4
23
27
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.3
11.3
36
81
A02BC02
ATC
pantoprazole; systemic
2.9
11.3
115
658
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
26.9
11.3
15
6
Z2221
NOMESCO Finland
Medical doctor
3.4
11.3
66
259
WX110
NOMESCO Finland
Local anesthesy
3.3
11.1
151
1036
K04.5
ICD-10 Finland
Chronic apical periodontitis
3.5
11.1
62
234
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
7.1
11.1
27
43
N06BA04
ATC
methylphenidate; oral
8.4
11.1
24
32
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
46.2
11.1
13
*
N03AX09
ATC
lamotrigine; oral
6.4
11.0
29
52
S18
ICPC
Laceration/cut
3.0
10.8
82
385
-1
NOMESCO Finland
NA
2.9
10.8
96
497
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
63.7
10.7
12
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
7.0
10.6
26
42
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
10.5
10.6
20
21
X59
ICD-10 Finland
Exposure to unspecified factor
3.4
10.5
59
221
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
116.2
10.5
11
*
F19.40
ICD-10 Finland
Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures
+∞
10.5
10
*
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
+∞
10.5
10
*
F16.00
ICD-10 Finland
Intoxication caused by hallucinogens uncomplicated
+∞
10.5
10
*
SAA01
NOMESCO Finland
Simple examination of mouth
3.3
10.5
156
1114
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
25.0
10.4
14
6
Y07
ICD-10 Finland
Other maltreatment
25.0
10.4
14
6
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.5
10.3
38
100
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.7
10.3
26
44
F39
ICD-10 Finland
Unspecified mood [affective] disorder
13.2
10.1
17
14
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
27.7
9.9
13
5
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
58.0
9.8
11
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.7
9.7
99
548
P27
ICPC
Fear of mental disorder
13.3
9.6
16
13
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
105.0
9.5
10
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
105.0
9.5
10
*
F12.24
ICD-10 Finland
Addiction caused by cannabis active addiction
105.0
9.5
10
*
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
11.5
9.5
17
16
A06AD11
ATC
lactulose; oral
5.5
9.5
28
58
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.6
9.5
109
645
F12.20
ICD-10 Finland
Dependence caused by cannabis currently independent
+∞
9.4
9
*
F11.2
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, dependence syndrome
+∞
9.4
9
*
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
+∞
9.4
9
*
F16.20
ICD-10 Finland
Dependence relationship caused by hallucinogens currently independent
+∞
9.4
9
*
F16.9
ICD-10 Finland
Mental and behavioural disorders due to use of hallucinogens, unspecified mental and behavioural disorder
+∞
9.4
9
*
30470
ICD-8 Finland
Drug dependence, Hallucinogenics
+∞
9.4
9
*
F16.24
ICD-10 Finland
Addiction relationship caused by hallucinogens active addiction
+∞
9.4
9
*
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
+∞
9.4
9
*
F12.21
ICD-10 Finland
Dependence caused by cannabis currently independent but staying in a controlling environment
+∞
9.4
9
*
T40.2
ICD-10 Finland
Poisoning: Other opioids
+∞
9.4
9
*
F16.29
ICD-10 Finland
Addiction caused by hallucinogens UNS
+∞
9.4
9
*
N05CF02
ATC
zolpidem; oral
3.6
9.1
44
147
Z03
ICPC
Housing/neighbourhood problem
38.7
9.1
11
*
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
38.7
9.1
11
*
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
19.8
9.1
13
7
WX290
NOMESCO Finland
Other blockade of nerve
2.6
9.0
120
757
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
25.5
9.0
12
5
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
25.5
9.0
12
5
RS220
NOMESCO Finland
NA
15.0
8.8
14
10
F41.8
ICD-10 Finland
Other specified anxiety disorders
7.6
8.8
20
29
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
8.9
8.8
18
22
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
52.5
8.8
10
*
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
52.5
8.8
10
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.8
8.7
38
117
C07AB07
ATC
bisoprolol; oral
3.0
8.6
59
251
F22.0
ICD-10 Finland
Delusional disorder
21.2
8.6
12
6
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
21.2
8.6
12
6
ZXY49
NOMESCO Finland
Other health care provider
29.0
8.6
11
*
N05AD03
ATC
melperone; systemic
29.0
8.6
11
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
29.0
8.6
11
*
IFC99
NOMESCO Finland
Other biological psychiatric intervention
94.1
8.5
9
*
P99
ICPC
Psychological disorders other
7.1
8.4
20
31
P29
ICPC
Psychological sympt/compl other
4.2
8.4
32
87
F16.52
ICD-10 Finland
Psychotic disorder caused by hallucinogens mainly hallucinations
+∞
8.4
8
*
F13.21
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment
+∞
8.4
8
*
F19.53
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic
+∞
8.4
8
*
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
+∞
8.4
8
*
F12.25
ICD-10 Finland
Dependence caused by cannabis continuous use
+∞
8.4
8
*
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
+∞
8.4
8
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.5
8.4
117
748
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
15.4
8.3
13
9
QAB00
NOMESCO Finland
Suture of skin of head or neck
15.4
8.3
13
9
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.5
8.2
24
49
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
12.5
8.2
14
12
IGV01
NOMESCO Finland
Psychiatric network contact
18.2
8.2
12
7
IEY01
NOMESCO Finland
Psychoeducation, individual
18.2
8.2
12
7
R44.3
ICD-10 Finland
Hallucinations, unspecified
35.0
8.2
10
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
35.0
8.2
10
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
35.0
8.2
10
*
N05CD02
ATC
nitrazepam; oral
23.2
8.1
11
5
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.5
8.0
23
46
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.6
8.0
37
119
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.6
8.0
72
361
SPAT1301
SPAT
No procedures
2.7
8.0
63
291
N03AX16
ATC
pregabalin; oral
3.0
7.9
48
190
L17
ICPC
Foot/toe symptom/complaint
3.1
7.9
47
183
Y04.2
ICD-10 Finland
Assault by bodily force by friend
46.9
7.8
9
*
K02.1
ICD-10 Finland
Caries of dentine
2.5
7.8
133
929
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
12.6
7.7
13
11
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
19.3
7.7
11
6
ZXY60
NOMESCO Finland
2-person team, nurses
19.3
7.7
11
6
N03AX12
ATC
gabapentin; oral
3.8
7.7
33
100
WX730
NOMESCO Finland
Conventional respirator
26.2
7.6
10
*
S02.40
ICD-10 Finland
Fracture of malar and maxillary bones, closed
26.2
7.6
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
7.6
42
154
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
8.2
7.6
16
21
M54.9
ICD-10 Finland
Dorsalgia, unspecified
4.0
7.5
30
85
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
83.2
7.5
8
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
7.4
34
109
IFC01
NOMESCO Finland
Withdrawal and replacement therapy for opioid addiction
+∞
7.3
7
*
F19.49
ICD-10 Finland
Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances UNS
+∞
7.3
7
*
F19.03
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances with delirium
+∞
7.3
7
*
F19.39
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS
+∞
7.3
7
*
O98.4
ICD-10 Finland
Viral hepatitis complicating pregnancy, childbirth and the puerperium
+∞
7.3
7
*
Z04.0
ICD-10 Finland
Blood-alcohol and blood-drug test
+∞
7.3
7
*
F11.9
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder
+∞
7.3
7
*
F11.39
ICD-10 Finland
Withdrawal symptoms caused by opiates without information about seizures
+∞
7.3
7
*
F16.53
ICD-10 Finland
Psychotic disorder caused by polymorphic hallucinogens
+∞
7.3
7
*
IGY02
SPAT
NA
16.6
7.3
11
7
S29
ICPC
Skin symptom/complaint other
3.4
7.3
36
122
K08.3
ICD-10 Finland
Retained dental root
6.1
7.3
19
34
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
3.9
7.2
29
83
F21
ICD-10 Finland
Schizotypal disorder
31.3
7.2
9
*
F92.0
ICD-10 Finland
Depressive conduct disorder
31.3
7.2
9
*
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
21.0
7.2
10
5
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
21.0
7.2
10
5
S97
ICPC
Chronic ulcer skin
12.7
7.2
12
10
SPAT1148
SPAT
Treatment of chronic ulcer or burn
5.0
7.2
22
48
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
7.1
69
356
ZYC01
NOMESCO Finland
Remote contact by phone
6.3
7.1
18
31
KMAK
NOMESCO Finland
NA
2.3
6.9
118
798
F99
ICD-10 Finland
Mental disorder, not otherwise specified
7.7
6.9
15
21
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.2
6.8
37
132
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
41.6
6.8
8
*
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
41.6
6.8
8
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.9
6.8
18
33
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
8.3
6.7
14
18
N05AX13
ATC
paliperidone; systemic
23.5
6.7
9
*
P74
ICPC
Anxiety disorder/anxiety state
4.7
6.7
22
52
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
6.7
56
264
A97
ICPC
No disease
3.2
6.7
36
128
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
2.5
6.7
57
275
N06AX12
ATC
bupropion; oral
3.6
6.6
29
90
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.9
6.6
43
175
S10
ICPC
Boil/carbuncle
5.6
6.5
18
35
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.6
6.5
18
35
R60.0
ICD-10 Finland
Localized oedema
5.6
6.5
18
35
SPAT1260
SPAT
Consultation of another employee
3.1
6.5
37
139
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.5
6.5
30
97
A28
ICPC
Limited function/disability NOS
5.9
6.5
17
31
N06AX21
ATC
duloxetine; oral
3.4
6.5
31
103
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
15.0
6.5
10
7
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
72.2
6.5
7
*
EBA30
NOMESCO Finland
Excision of root of tooth
6.4
6.5
16
27
L12
ICPC
Hand/finger symptom/complaint
3.1
6.3
35
128
N80
ICPC
Head injury other
18.8
6.3
9
5
F60.8
ICD-10 Finland
Other specific personality disorders
18.8
6.3
9
5
T40.4
ICD-10 Finland
Poisoning: Other synthetic narcotics
+∞
6.3
6
*
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
+∞
6.3
6
*
3045A
ICD-9 Finland
Drug dependence, Hallucinogen dependence
+∞
6.3
6
*
F16.50
ICD-10 Finland
Psychotic disorder caused by hallucinogens schizophrenic
+∞
6.3
6
*
3043A
ICD-9 Finland
Drug dependence, Cannabis dependence
+∞
6.3
6
*
F19.22
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication
+∞
6.3
6
*
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
+∞
6.3
6
*
F16.79
ICD-10 Finland
Residual or late-onset psychosis caused by hallucinogens UNS
+∞
6.3
6
*
F12.26
ICD-10 Finland
Addiction caused by cannabis intermittent drug addiction
+∞
6.3
6
*
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
+∞
6.3
6
*
F19.56
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances of mixed type
+∞
6.3
6
*
F16.5
ICD-10 Finland
Mental and behavioural disorders due to use of hallucinogens, psychotic disorder
+∞
6.3
6
*
SPAT1227
SPAT
Substance abuse rehabilitation
27.7
6.3
8
*
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
27.7
6.3
8
*
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
27.7
6.3
8
*
SPAT1274
SPAT
Brief intervention in person with addiction symptoms
27.7
6.3
8
*
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
27.7
6.3
8
*
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
27.7
6.3
8
*
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.3
6.2
74
418
SPAT1254
SPAT
Administration of medicine
3.1
6.2
35
130
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.8
6.2
25
72
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
7.1
6.2
14
21
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
13.1
6.2
10
8
A01
ICPC
Pain general/multiple sites
4.4
6.1
21
52
A41.9
ICD-10 Finland
Sepsis, unspecified
10.5
6.1
11
11
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
6.1
29
96
R02
ICPC
Shortness of breath/dyspnoea
4.0
6.1
23
63

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
99
63
30.73
124.55
11.5
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
110
115
20.52
104.82
14.9
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
112
130
18.77
99.39
12.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
113
162
15.11
85.24
12.8
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
47
10
61.51
82.22
2.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
114
177
14.00
80.47
11.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
114
178
13.92
80.07
13.9
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
113
176
13.80
79.44
13.5
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
109
174
12.86
74.58
14.1
1.3
—
—
—
0
0
(4198724)
44
12
46.99
72.42
11.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
147
504
8.67
45.34
4.9
3.2
u/l
40.6
33.5
1.00
134
479
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
115
314
7.44
44.84
3.9
1.7
%
1.7
1.4
3.51
98
299
(3009508) Creatinine [Moles/volume] in Urine
118
364
6.63
39.34
10.9
3.1
mmol/l
6.6
9.4
5.07
99
317
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
34
25
16.24
37.46
25.0
25.1
nmol/l
1232.6
1252.4
0.04
34
25
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
147
614
6.58
33.08
6.1
6.4
umol/l
9.6
11.6
1.84
139
588
(3002032) Base excess in Venous blood by calculation
47
85
6.96
26.37
2.9
3.7
mmol/l
1.3
1.9
0.25
29
71
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
122
522
4.54
24.17
5.4
7.3
mmol/l
1.2
1.2
1.09
100
439
(3019309) Folate [Moles/volume] in Red Blood Cells
58
142
5.38
23.49
1.8
1.6
nmol/l
1174.7
1208.0
0.10
44
111
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
113
471
4.30
22.88
4.2
6.6
mmol/l
1.2
1.2
0.78
105
433
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
23
20
12.90
22.65
13.3
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
79
258
4.45
22.27
6.8
4.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
172
994
6.96
22.15
8.9
7.1
u/l
77.6
71.6
2.25
161
939
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
49
110
5.61
21.77
5.9
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
122
553
4.19
21.58
3.4
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
102
410
4.10
21.41
2.2
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
87
317
4.14
20.91
3.1
1.9
u/l
200.1
395.7
0.48
81
305
(3018418) pH of Serum or Plasma
86
323
3.96
19.58
2.4
4.0
ph
7.4
7.4
0.17
14
61
(3013826) Glucose [Moles/volume] in Serum or Plasma
137
704
4.14
19.54
5.6
5.0
mmol/l
6.3
6.6
0.90
128
649
(3017143) Hepatitis C virus Ab [Presence] in Serum
84
313
3.95
19.30
2.2
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
88
348
3.77
18.36
14.3
6.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
127
644
3.76
17.93
11.6
7.9
e9/l
0.0
0.0
0.62
98
530
(3000991) Gas panel - Venous blood
39
85
5.48
17.71
3.8
8.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
100
438
3.62
17.70
7.0
5.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
60
6.18
17.01
1.1
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
131
695
3.67
16.87
10.8
6.0
e9/l
0.6
0.6
1.69
113
620
(3006315) Basophils [#/volume] in Blood
131
696
3.66
16.81
10.8
6.0
e9/l
0.0
0.0
0.34
113
625
(3021879) Hepatitis B virus core Ab [Presence] in Serum
63
212
3.91
16.43
1.9
1.7
—
—
—
0
0
(3015736) pH of Urine
110
533
3.42
16.20
8.8
2.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
32
63
5.88
16.15
4.3
4.7
mmol/l
26.0
24.6
1.38
32
63
(3019198) Lymphocytes [#/volume] in Blood
133
730
3.56
15.85
10.7
6.1
e9/l
2.3
1.9
2.66
114
664
(3024561) Albumin [Mass/volume] in Serum or Plasma
102
479
3.35
15.69
4.4
4.7
g/l
36.3
37.8
1.69
96
453
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
33
7.76
15.62
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
99
4.82
15.60
1.5
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
131
721
3.46
15.36
14.7
6.6
e9/l
0.2
0.2
1.17
115
651
(3013650) Neutrophils [#/volume] in Blood by Automated count
141
829
3.50
14.48
24.3
9.5
e9/l
4.4
4.0
0.77
123
734
(3022096) Basophils/100 leukocytes in Blood
118
639
3.13
13.67
8.7
5.7
%
0.5
0.7
3.95
113
609
(3024928) Oxygen saturation in Venous blood
16
17
10.16
13.62
1.5
2.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
84
377
3.15
13.53
2.0
1.7
pmol/l
93.2
95.2
0.16
41
200
(3019069) Monocytes/100 leukocytes in Blood
120
666
3.07
13.12
9.2
5.8
%
8.1
8.4
0.55
115
640
(3006504) Eosinophils/100 leukocytes in Blood
119
658
3.06
13.09
8.9
5.7
%
2.8
2.8
0.06
114
630
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
41
6.22
12.75
1.3
1.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
123
703
3.01
12.56
8.7
5.5
%
29.8
29.5
0.12
117
677
(3003396) Base excess in Arterial blood by calculation
37
102
4.24
12.47
4.2
13.0
mmol/l
1.3
0.6
0.49
28
81
(3031040) Bacteria [#/volume] in Urine by Automated count
132
798
3.00
11.91
4.3
3.5
e6/l
443.2
86.0
—
6
8
(3018010) Neutrophils/100 leukocytes in Blood
120
692
2.89
11.79
8.8
5.4
%
55.2
56.2
0.40
115
668
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
59
233
3.19
11.58
2.3
1.8
mg/l
2.2
2.8
1.41
52
204
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
173
1238
4.39
11.49
7.2
2.7
u/l
44.0
38.2
0.79
163
1192
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
149
3.52
11.01
2.3
2.4
umol/l
9.1
10.4
0.15
33
124
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
47
169
3.34
10.69
2.2
2.4
e6/l
6.1
2.2
1.21
24
84
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
57
4.88
10.61
2.2
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
10
0
+∞
10.51
19.5
0.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
58
4.79
10.39
1.4
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
15
9.21
10.35
1.2
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
76
365
2.77
10.32
3.4
2.7
e6/l
72.1
51.5
0.21
57
284
(3016502) Oxygen saturation in Arterial blood
32
92
3.96
10.12
4.2
14.1
%
96.4
96.1
0.18
32
85
(3018095) Leukocytes [#/volume] in Urine
86
444
2.67
10.07
3.6
3.2
e6/l
120.1
138.4
0.07
58
300
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
82
414
2.69
10.04
3.3
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
70
330
2.74
9.77
3.2
2.5
e6/l
1.2
0.3
0.59
51
248
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
77
383
2.66
9.64
3.4
2.7
u/l
48.9
57.1
1.74
70
360
(3023103) Potassium [Moles/volume] in Serum or Plasma
185
1452
5.88
9.39
20.5
9.9
mmol/l
3.9
3.9
0.19
177
1401
(3019550) Sodium [Moles/volume] in Serum or Plasma
184
1442
5.51
9.27
20.5
9.9
mmol/l
139.2
139.7
1.83
177
1395
(3023520) Reticulocytes [#/volume] in Blood
20
43
5.07
9.05
4.0
2.7
e9/l
77.6
74.4
0.12
14
31
(36304419) Bacteria [Presence] in Urine
69
337
2.62
8.85
3.2
2.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
23
59
4.28
8.42
5.0
10.7
%
0.5
0.7
1.48
23
59
(3015377) Calcium [Moles/volume] in Serum or Plasma
69
347
2.53
8.24
3.8
3.0
mmol/l
2.3
2.4
0.82
64
321
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
182
2.91
8.24
2.1
2.4
e6/l
0.6
0.6
0.01
23
99
(3002173) Hemoglobin [Mass/volume] in Arterial blood
29
90
3.61
8.18
4.3
14.1
g/l
133.9
130.3
0.51
29
82
(3042936) Bacteria identified in Isolate by Culture
40
154
3.01
7.98
2.1
2.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
44
179
2.88
7.96
1.8
1.6
pmol/l
452.0
423.5
0.32
39
166
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
76
411
2.39
7.66
2.9
2.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
170
2.87
7.65
1.8
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
33
117
3.19
7.55
1.6
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
128
868
2.37
7.55
4.7
2.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
22
60
4.00
7.42
5.1
10.6
%
2.4
1.7
0.77
22
60
(3027315) Oxygen [Partial pressure] in Blood
15
30
5.33
7.31
6.5
1.7
kpa
8.8
9.5
0.72
15
30
(3013290) Carbon dioxide [Partial pressure] in Blood
15
30
5.33
7.31
6.5
1.7
kpa
5.3
5.2
0.28
15
30
(3012501) Base excess in Blood by calculation
15
30
5.33
7.31
6.5
1.7
mmol/l
2.2
2.2
—
10
18
(3026782) Osmolality of Urine
51
236
2.57
7.14
3.8
2.1
mosm/kgh2o
532.4
582.4
0.69
46
203
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
93
3.35
7.11
1.4
1.5
miu/ml
193.4
290.7
—
5
57
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
168
1315
2.94
6.90
6.3
3.9
mu/l
1.6
1.8
1.68
156
1238
(3026008) Bacteria identified in Urine by Culture
53
254
2.49
6.87
3.4
2.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
11
17
6.80
6.85
4.8
1.3
%
15.4
17.3
—
6
6
(21494755) Public health laboratory ask at order entry panel
9
346
0.22
6.78
1.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
35
137
2.89
6.74
1.9
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
147
1088
2.40
6.66
5.1
3.5
pmol/l
14.8
14.6
0.62
136
1006
(3014007) Fractional oxyhemoglobin in Arterial blood
21
60
3.80
6.64
5.3
10.6
%
93.7
93.4
0.12
21
60
(1616796) Gas panel - Central venous blood
14
29
5.12
6.56
7.4
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
121
2.97
6.54
1.6
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
71
395
2.25
6.52
5.7
5.0
inr
1.1
1.1
0.19
29
134
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
42
4.34
6.50
1.9
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
18
48
4.03
6.24
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
77
453
2.15
6.08
3.2
2.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
137
1016
2.16
5.71
3.6
3.1
mm/h
10.8
7.3
2.57
125
950
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
171
1401
2.73
5.48
17.2
8.3
ml/min/173m2
102.5
97.6
2.12
134
1138
(3013512) EKG study
50
258
2.26
5.38
4.5
2.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
126
919
2.04
5.32
4.6
3.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
67
391
2.08
5.28
4.8
2.7
ng/l
13.2
28.5
1.19
38
180
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
245
0.22
4.93
1.2
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
10
9.36
4.83
4.2
2.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
181
1565
3.05
4.49
20.6
9.6
mg/l
21.5
21.4
0.01
156
1157
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
187
1682
3.43
4.42
15.6
7.9
u/l
41.5
31.7
3.22
181
1633
(1761868) Lipid panel - Serum or Plasma
41
694
0.48
4.20
2.9
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
163
1360
2.18
4.12
5.6
3.0
mmol/l
6.0
5.8
0.93
154
1264
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
53
3.20
4.07
2.9
17.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
25
111
2.44
3.73
1.9
1.5
mu/l
527.1
276.6
1.30
18
100
(40768797) Stomach Pathology biopsy report
31
152
2.23
3.71
1.1
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
17
62
2.91
3.69
3.1
11.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
32
3.58
3.38
2.7
2.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
92
2.44
3.23
3.3
2.6
u/l
4847.5
793.7
—
8
37
(3029937) Albumin [Presence] in Urine by Test strip
53
332
1.82
3.21
5.6
3.1
estimate
0.0
0.0
0.50
16
123
(3035947) Staphylolysin Ab [Units/volume] in Serum
6
8
7.69
3.07
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
46
281
1.83
3.01
3.5
3.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
17
4.86
2.95
4.8
1.9
g/l
122.6
131.5
—
8
10
(3022806) Fractional oxyhemoglobin in Capillary blood
7
13
5.54
2.89
2.6
1.2
%
88.7
91.3
—
7
13
(40760892) CBC W Ordered Manual Differential panel - Blood
55
363
1.72
2.75
6.5
5.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
10
6.15
2.72
1.5
1.0
%
11.4
13.2
—
6
10
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
19
4.34
2.71
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
341
0.45
2.61
1.5
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
149
1277
1.70
2.55
5.1
4.0
mmol/mol
36.9
38.2
0.77
135
1223
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
36
216
1.82
2.48
3.5
2.7
ng/l
118.6
1392.8
1.14
23
125
(3018405) Lactate [Moles/volume] in Arterial blood
10
34
3.05
2.45
3.8
6.4
mmol/l
1.1
1.2
—
10
34
(40761536) Microorganisms panel - Urine sediment
23
119
2.06
2.42
6.1
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
47
308
1.69
2.39
1.7
1.6
mg/l
1.1
0.9
0.28
31
223
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
28
3.32
2.34
2.1
4.7
e9/l
3.8
3.6
—
9
28
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
29
3.20
2.25
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
29
3.20
2.25
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
29
3.20
2.25
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
29
3.20
2.25
2.1
4.8
%
51.3
54.7
—
9
29
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
9
5.67
2.22
6.0
4.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
14
4.38
2.16
2.5
2.6
mmol/l
6.7
7.3
—
6
14
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
10
5.10
2.08
1.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
15
4.09
2.05
1.0
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
181
1672
2.08
2.03
17.5
8.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
32
2.90
2.03
1.7
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
17
85
2.09
1.97
2.1
1.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
16
3.83
1.95
1.0
2.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
85
673
1.46
1.84
4.7
2.8
estimate
0.0
0.0
0.00
17
121
(3041354) Potassium [Moles/volume] in Venous blood
5
12
4.24
1.83
2.6
2.2
mmol/l
4.0
4.1
—
5
12
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
12
4.24
1.83
2.6
2.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
12
4.24
1.83
2.6
2.2
mmol/l
107.2
105.9
—
5
12
(3021601) Nitrite [Presence] in Urine by Test strip
84
667
1.45
1.78
5.8
4.0
estimate
0.0
0.0
0.00
17
128
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
13
3.92
1.72
1.2
1.0
iu/ml
580.2
234.9
—
5
13
(3000494) Fungus identified in Specimen by Culture
25
151
1.75
1.70
1.2
1.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
11
49
2.32
1.67
1.0
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
83
666
1.43
1.63
4.7
2.8
estimate
0.0
0.0
0.00
16
126
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
142
0.40
1.60
1.2
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
27
2.65
1.53
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
9
38
2.43
1.47
4.3
5.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
16
88
1.89
1.46
1.8
3.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
111
1.79
1.45
5.8
4.0
%
0.6
0.8
—
8
30
(1761482) Bacteria [#/volume] in Urine by Culture
6
22
2.78
1.44
7.5
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.38
1.5
2.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
42
2.20
1.35
1.2
1.3
e6/l
328544.3
267.8
—
9
35
(3021440) Promyelocytes/100 leukocytes in Blood
18
106
1.77
1.35
6.1
4.1
%
0.1
0.2
—
8
26
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
24
2.55
1.31
2.8
3.2
u/ml
6.6
4.9
—
6
19
(3044290) Cell count panel - Cerebral spinal fluid
8
34
2.41
1.31
1.1
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
34
2.41
1.31
1.3
3.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
18
2.82
1.29
1.4
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
18
2.82
1.29
1.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
100
1.77
1.28
1.1
1.2
—
15.3
—
0
5
(3000330) Specific gravity of Urine by Test strip
9
45
2.05
1.25
5.2
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
45
2.05
1.25
1.1
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
129
0.45
1.21
2.0
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
43
322
1.43
1.20
2.0
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
38
2.15
1.20
2.3
1.8
—
—
—
0
0
(3039000) Anion gap in Blood
6
26
2.35
1.19
2.0
22.0
mmol/l
12.2
11.4
—
6
19
(3018572) Chloride [Moles/volume] in Blood
6
26
2.35
1.19
2.0
22.0
mmol/l
105.2
104.9
—
6
19
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
45
341
1.41
1.18
1.6
1.7
mmol/l
1.6
1.5
0.12
40
294
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
80
1.81
1.16
2.1
2.0
ml/min/173m2
54.4
80.9
—
5
26
(3003327) Ova and parasites identified in Stool by Light microscopy
12
65
1.90
1.16
1.4
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
177
1.54
1.15
2.3
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
23
154
1.56
1.10
5.7
6.1
mmol/l
1.1
1.0
0.32
23
145
(3044640) Blood type and Crossmatch panel - Blood
48
373
1.38
1.09
2.0
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
225
1.45
1.03
2.5
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
37
278
1.41
1.02
2.0
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
171
1618
1.45
0.93
26.8
9.7
%
41.2
42.2
1.02
125
1394
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
28
2.18
0.92
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
5
105
0.46
0.91
1.4
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
111
1.58
0.91
5.5
6.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
16
103
1.60
0.90
6.8
4.1
%
0.0
0.0
—
6
25
(40768443) Skin Pathology biopsy report
8
46
1.77
0.83
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
46
1.77
0.83
1.1
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
47
1.73
0.81
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
25
183
1.42
0.81
2.0
2.6
ng/l
409.6
492.9
0.15
17
141
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
48
1.69
0.79
1.4
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
24
0.00
0.79
0.0
1.3
—
7.4
—
0
16
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
24
0.00
0.79
0.0
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
24
0.00
0.79
0.0
6.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
34
1.79
0.77
1.3
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
188
1827
1.71
0.76
37.7
13.9
e9/l
253.4
252.0
0.09
182
1791
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
170
0.63
0.74
1.2
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
39
1.82
0.73
1.9
2.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
39
1.82
0.73
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
41
1.73
0.70
2.1
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
61
1.67
0.70
1.6
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
61
1.67
0.70
2.7
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
62
531
1.25
0.69
5.6
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
42
1.69
0.69
2.0
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
86
1.55
0.68
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
57
485
1.25
0.67
1.8
1.6
—
—
—
0
0
(3000492) Spirometry study
14
200
0.68
0.67
1.4
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
28
1.81
0.66
2.2
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
28
1.81
0.66
1.0
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
188
1834
1.61
0.66
37.5
13.8
e12/l
4.7
4.8
1.63
181
1798
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
30
1.68
0.62
1.2
1.8
—
—
—
0
0
(4268621)
0
21
0.00
0.60
0.0
2.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
22
0.00
0.59
0.0
5.0
—
1038.5
—
0
22
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
35
1.74
0.58
1.0
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
88
0.56
0.57
1.2
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
188
1837
1.57
0.57
37.5
13.9
e9/l
7.8
6.6
7.79
181
1801
(3007164) IgA [Mass/volume] in Serum or Plasma
43
366
1.22
0.51
1.3
1.4
g/l
2.5
2.2
0.54
26
235
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
87
1.40
0.43
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
31
1.63
0.43
1.2
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
160
1541
1.21
0.43
4.5
3.4
mmol/l
2.7
2.9
2.80
147
1456
(3015183) Erythrocyte sedimentation rate
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
64
577
1.16
0.41
3.7
3.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
19
0.00
0.39
0.0
1.6
—
6.6
—
0
9
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.1
—
289.6
—
0
13
(4035726)
5
78
0.63
0.36
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
80
0.62
0.36
1.2
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
43
1.41
0.35
1.8
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
44
1.37
0.34
1.5
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
66
1.22
0.27
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
30
265
1.16
0.25
3.5
3.8
mg/l
25.9
82.5
2.11
20
174
(3002256) Pathology report gross observation
16
133
1.22
0.25
1.4
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
76
1.19
0.25
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
11
87
1.28
0.25
8.0
4.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
238
1.16
0.23
1.3
1.3
iu/ml
23.4
20.9
—
8
66
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
210
0.84
0.23
1.5
2.1
ug/l
0.4
0.6
0.78
11
94
(3050129) First trimester maternal screen panel - Serum or Plasma
7
94
0.74
0.23
1.0
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
156
1522
1.12
0.23
4.0
3.2
mmol/l
1.3
1.4
2.47
144
1442
(4034850)
5
40
1.26
0.22
13.2
10.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
31
278
1.14
0.22
4.7
4.7
mg/mmol
4.7
13.5
1.62
19
187
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
0.9
—
0
11
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
4.2
—
8.5
—
0
11
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
10
0.00
0.21
0.0
1.2
—
66.8
—
0
10
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(4146454)
0
10
0.00
0.21
0.0
3.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
5.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(4027681)
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.2
—
2.9
—
0
12
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
37.3
—
0
8
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
39
357
1.12
0.20
2.2
2.8
ug/l
0.9
1.3
1.30
31
329
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
156
1527
1.11
0.19
4.1
3.3
mmol/l
4.3
4.7
5.72
145
1450
(3041096) Erythrocytes [Presence] in Urine by Automated
44
408
1.10
0.18
5.1
2.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
45
419
1.10
0.17
1.5
1.3
u/ml
0.5
1.0
1.81
11
102
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5
70
0.71
0.17
3.2
5.8
ug/l
2.5
61.9
—
5
59
(4010399)
8
69
1.17
0.16
2.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
23
255
0.89
0.16
2.6
2.5
ug/g
96.3
143.4
0.65
15
211
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
20
222
0.89
0.14
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
113
1.16
0.13
1.4
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
149
1467
1.07
0.11
3.7
3.0
mmol/l
1.5
1.3
0.92
140
1391
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.3
u/ml
172.6
193.2
—
5
25
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
45
1.11
0.10
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
90
1.12
0.05
1.1
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
144
1454
0.96
0.05
3.6
3.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
150
1.07
0.04
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
45
461
0.97
0.03
1.6
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
215
1.03
0.00
1.1
1.3
u/ml
1.2
4.1
—
9
99
(3022145) Colonoscopy Study observation
14
142
0.98
0.00
1.2
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
108
1.02
0.00
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
48.3
—
0
7
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
201.5
—
0
8
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
3.0
2.2
ng/l
38.6
107.2
—
5
41
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
9.2
—
0
7
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
0
7
0.00
0.00
0.0
3.3
—
10.1
—
0
7
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
7
0.00
0.00
0.0
3.0
—
29.1
—
0
7
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
6.4
—
0
7
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
5.0
—
17.1
—
0
7
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
62.3
—
0
6
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
6.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
47
470
1.00
0.00
1.4
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
57
0.87
0.00
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
50.5
—
0
6
(4038314)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
6.2
—
0
5
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
13.4
—
0
6
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4024509)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1893.0
—
0
5
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
131.2
—
0
5
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
119.7
—
0
6
(40768800) Prostate Pathology biopsy report
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
61
0.98
0.00
1.7
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
96
0.93
0.00
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
57
0.87
0.00
1.2
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
9.1
—
0
6
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_HALLUCIN and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
F5_HALLUCIN 9.052 [6.5, 12.62] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 233 out of 1407 males with F5_HALLUCIN died.

Mortality risk

Mortality risk for people of age

years, who have F5_HALLUCIN.

N-year risk Females Males
1 No data 1.919%
5 No data 10.149%
10 No data 22.265%
15 No data 38.274%
20 No data 56.046%

Relationships between endpoints

↥

Index endpoint: F5_HALLUCIN – Mental and behavioural disorders due to hallucinogens

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data